HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report) was the target of a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 900 shares, a drop of 43.8% from the August 31st total of 1,600 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 9.0 days.
HLS Therapeutics Stock Performance
HLS Therapeutics stock remained flat at $2.60 during trading hours on Thursday. 100 shares of the company’s stock traded hands, compared to its average volume of 710. The company’s fifty day moving average is $2.38 and its two-hundred day moving average is $2.82. HLS Therapeutics has a 1 year low of $2.22 and a 1 year high of $4.00.
About HLS Therapeutics
Read More
- Five stocks we like better than HLS Therapeutics
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- P/E Ratio Calculation: How to Assess Stocks
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- How to Invest in the Best Canadian Stocks
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for HLS Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HLS Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.